Publication details

Report of termination of the clinical trial in the Czech Republic TUD-2DAUNO-058



Year of publication 2020
MU Faculty or unit

Faculty of Medicine

Attached files
Description EudraCT 2013-003191-12 Randomized comparison between two dose levels of daunorubicin and between one versus two cycles of induction therapy for adult patients with acute myeloid leukemia over 60 years. Clinical Trial Termination Information provides a comprehensive overview of clinical trial (KH) information. It describes the course of KH, including a brief description, lists KH centers and their principal investigators, and provides information on KH subjects (number of patients enrolled, number of patients who completed the study, and number of patients who did not complete it). It also contains safety information and monitored efficacy parameters, measures taken during KH, and information on audits performed.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info